(Q39279748)

10 September 2017

2 references

22 October 2022

Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology (English)

1 reference

10 September 2017

1 reference

1 reference

human coronavirus

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28466096%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Rudragouda Channappanavar

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28466096%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

2 May 2017

1 reference

PubMed ID

28466096

Seminars in Immunopathology

10 September 2017

1 July 2017

1 reference

22 October 2022

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28466096%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

22 October 2022

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28466096%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28466096%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

529-539

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28466096%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00281-017-0629-x

8 June 2020

exact match

0 references

cites work

Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary Perspectives

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Clinical disease in children associated with newly described coronavirus subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Coronaviruses post-SARS: update on replication and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Replication and shedding of MERS-CoV in upper respiratory tract of inoculated dromedary camels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Middle East respiratory syndrome coronavirus: a case-control study of hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Middle East respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

SARS: clinical virology and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

The pathology and pathogenesis of experimental severe acute respiratory syndrome and influenza in animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Multiple organ infection and the pathogenesis of SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Lung pathology of fatal severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Expression of lymphocytes and lymphocyte subsets in patients with severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

A cluster of patients with severe acute respiratory syndrome in a chest ward in southern Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Clinicopathologic, Immunohistochemical, and Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates, April 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Disease-promoting effects of type I interferons in viral, bacterial, and coinfections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Age-dependent dysregulation of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Cytokine responses in severe acute respiratory syndrome coronavirus-infected macrophages in vitro: possible relevance to pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Modeling the early events of severe acute respiratory syndrome coronavirus infection in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Persistence of lung inflammation and lung cytokines with high-resolution CT abnormalities during recovery from SARS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Analysis of serum cytokines in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Human immunopathogenesis of severe acute respiratory syndrome (SARS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

An interferon-gamma-related cytokine storm in SARS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

A probable role for IFN-gamma in the development of a lung immunopathology in SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Middle East respiratory syndrome coronavirus shows poor replication but significant induction of antiviral responses in human monocyte-derived macrophages and dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

SARS-CoV pathogenesis is regulated by a STAT1 dependent but a type I, II and III interferon receptor independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Exacerbated innate host response to SARS-CoV in aged non-human primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

The PDZ-binding motif of severe acute respiratory syndrome coronavirus envelope protein is a determinant of viral pathogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Severe acute respiratory syndrome coronavirus E protein transports calcium ions and activates the NLRP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Infection with MERS-CoV causes lethal pneumonia in the common marmoset

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Intratracheal exposure of common marmosets to MERS-CoV Jordan-n3/2012 or MERS-CoV EMC/2012 isolates does not result in lethal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Receptor variation and susceptibility to Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Rapid generation of a mouse model for Middle East respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Animal models for SARS and MERS coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Animal models of Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

A mouse model for MERS coronavirus-induced acute respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Interaction of SARS and MERS Coronaviruses with the Antiviral Interferon Response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Coronavirus papain-like proteases negatively regulate antiviral innate immune response through disruption of STING-mediated signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Interferon and cytokine responses to SARS-coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

SARS-CoV nucleocapsid protein antagonizes IFN-β response by targeting initial step of IFN-β induction pathway, and its C-terminal region is critical for the antagonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Suppression of innate antiviral response by severe acute respiratory syndrome coronavirus M protein is mediated through the first transmembrane domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Initial viral load and the outcomes of SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Viral Load Kinetics of MERS Coronavirus Infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Macrophage-expressed IFN-β contributes to apoptotic alveolar epithelial cell injury in severe influenza virus pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Cellular inhibitor of apoptosis protein cIAP2 protects against pulmonary tissue necrosis during influenza virus infection to promote host survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Adaptive immune cells temper initial innate responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Transcriptomic analysis reveals a mechanism for a prefibrotic phenotype in STAT1 knockout mice during severe acute respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Induction of alternatively activated macrophages enhances pathogenesis during severe acute respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Genome Wide Identification of SARS-CoV Susceptibility Loci Using the Collaborative Cross

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Acute respiratory distress syndrome in critically ill patients with severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

SARS: systematic review of treatment effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

The use of corticosteroid as treatment in SARS was associated with adverse outcomes: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Corticosteroid treatment of severe acute respiratory syndrome in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Coronaviruses - drug discovery and therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

IFNλ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNα treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Silencing of CCR2 in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Therapeutic siRNA silencing in inflammatory monocytes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Immunomodulatory therapy for severe influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

The effect of inhibition of PP1 and TNFα signaling on pathogenesis of SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-017-0629-X

Clinical and laboratory findings of SARS in Singapore.

21 January 2018

1 reference

12 December 2020

Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome

1 reference

12 December 2020

Clinical spectrum of the Middle East respiratory syndrome coronavirus (MERS-CoV).

1 reference

12 December 2020

Not so fast: adaptive suppression of innate immunity

1 reference

12 December 2020

Proliferative growth of SARS coronavirus in Vero E6 cells

1 reference

12 December 2020

Coronavirus-associated pneumonia in previously healthy children

1 reference

12 December 2020

Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment.

1 reference

12 December 2020

10.1007/S00281-017-0629-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28466096%20AND%20SRC:MED&resulttype=core&format=json

release_5qhwcjf6e5eyhpbibbyiahdtbi

8 June 2020

Fatcat ID

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28466096%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference